UBS Group’s Carter's CRI Stock Holding History
Bought
Maintained
Sold
Other funds holding CRI
UBS Group's CRI Position: Q3 2026 in Review
UBS Group increased its Carter's (CRI) stake by 37% in Q3 2026, buying an estimated $9.17M and bringing the position to 943,534 shares worth $29.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2230.
UBS Group first reported a position in CRI in Q2 2013 and has held it in 54 quarters since. The position peaked at $87.5M in Q4 2024. 295 funds tracked by Wall St. Rank hold CRI as of Q3 2026.
- UBS Group held 943,534 shares of Carter's worth $29.5M as of Q3 2026.
- UBS Group bought 256,554 Carter's shares in Q3 2026, an estimated $9.17M.
- Carter's made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #2230 holding.
- UBS Group first reported a position in Carter's in Q2 2013 and has held it in 54 quarters since.
- UBS Group's Carter's position peaked at $87.5M in Q4 2024.
- 295 funds tracked by Wall St. Rank held Carter's as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.